Information  X 
Enter a valid email address

NB Glbl Fltg Rte Inc (NBLS)

  Print      Mail a friend

Friday 20 September, 2019

NB Glbl Fltg Rte Inc

Transaction in Own Shares (replacement)

RNS Number : 1130N
NB Global Floating Rate Income Fund
20 September 2019
 

The following replaces the announcement released at 07:00 on 20 September 2019 under RNS Number 0232N. The initial release incorrectly stated the number of Sterling Shares in issue as 57,081,191, which has been corrected in the below.  All other details of the announcement remain unchanged.

 

20 September 2019

 

NB Global Floating Rate Income Fund Limited

(the "Company")

Transaction in Own Shares

The Company announces that pursuant to the general authority granted by shareholders of the Company on 12 August 2019 to make market purchases of its own Ordinary shares, it repurchased 1,000,000 Sterling Shares at a price of 89.04 pence per Sterling Share, to be cancelled, on 19 September 2019. This represents approximately 0.1672 per cent of the Company's current issued Sterling Shares.

Following this transaction, the Company has in issue 597,081,191 Sterling Shares of which 75,000,000 are held in treasury. The Company also has 30,537,795 US Dollar Shares in issue of which 1,342,627 are held in treasury. US Dollar Shares have 1 vote per share and Sterling Shares have 1.6 votes per share.

For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should exclude any shares held in treasury and should use the figure of 864,525,073 voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

Enquiries:

 

Praxis Fund Services Limited

Company Secretary

 

Matt Falla/Gemma Woods

Tel: +44 (0) 1481 737 600

LEI: 549300P4FSBHZFALLG04

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSEANNEAEKNEEF

a d v e r t i s e m e n t